Clicky

Island Pharmaceuticals Limited(ILA)

Description: Island Pharmaceuticals Limited, a drug research and repurposing company, focuses on the development of preventative or therapeutic drugs for viral infections. Its lead product candidate is ISLA-101, a drug with safety profile for the prevention and treatment of dengue fever and other mosquito borne diseases. The company was founded in 2017 and is based in Camberwell, Australia.


Keywords: Medicine Medication Infectious Diseases Infection Viral Infections Tropical Diseases Dengue Fever Mosquito Myelitis

Home Page: www.islandpharmaceuticals.com

ILA Technical Analysis

AIM Growth Series
,

Phone: 800-959-4246


Officers

Name Title
Dr. Paul Donald Richard MacLeman M.B.A., MBA, BVSc, Grad Dip Tech, Grad Cert Eng, G Exec. Chairman
Dr. David Charles Foster MD, CEO, Pres & Exec. Director
Mr. Peter Gordon Webse B.Bus, FCIS, FCPA, FGIA, M.A.I.C.D., MAICD Company Sec.

Exchange: AU

Country: AU

Currency: Australian Dollar (A$)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 3.2935
Price-to-Sales TTM: 0
IPO Date:
Fiscal Year End: December
Full Time Employees: 0
Back to stocks